News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Michael Ong received $2.4M for metastatic prostate cancer – CCTG
Photo taken from CCTG/X
Aug 12, 2024, 01:27

Michael Ong received $2.4M for metastatic prostate cancer – CCTG

The Canadian Cancer Trials Group shared on X:

“Congratulations to Dr Michael Ong, who has received $2,487,015 over 7 years from CIHR to support the CCTG PR26 (TRIPLE-SWITCH) trial. The study aims to personalize chemotherapy use and improve survival for patients with metastatic prostate cancer.”

Read further.
Source: The Canadian Cancer Trials Group/X

cancer CCTG chemotherapy metastatic prostate cancer Michael Ong OncoDaily Oncology The Canadian Cancer Trials Group
Special Coverage
Blog
Mar 26, 2025, 19:51
A huge step in early cancer detection - Cizzle Bio
Blog
Mar 26, 2025, 19:40
Fabio Arcidiacono: Excellent overview of the role of SAbR in oligometastatic disease
Blog
Mar 26, 2025, 19:20
Giannis Mountzios: ELCC25 MARIPOSA trial - Overall Survival in 1L EGFR-mutant NSCLC
Insight
Mar 26, 2025, 19:10
Authors Explore the Need Advancing HPV-related Cancer Research and vaccination rates among Arab Americans - ACS Journal Cancer
Blog
Mar 26, 2025, 18:40
The journey living with multiple myeloma can be filled with numerous ups and downs - International Myeloma Foundation
Blog
Mar 26, 2025, 18:32
Juan Gómez Rivas: EAU25 Showcases Science, Innovation, and the Power of Connection in Urology
Blog
Mar 26, 2025, 18:26
Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact - AACR
Blog
Mar 26, 2025, 18:21
Climb of Life Event Has Raised Over £1.5M for Cancer Research Since 2007 - The ICR
Blog
Mar 26, 2025, 18:16
Eric K. Singhi: Breaking news - the Overall Survival results from MARIPOSA are out at ELCC25
Blog
Mar 26, 2025, 18:12
Submit an abstract for the AACR Special Conference
Blog
Mar 26, 2025, 18:03
Molecular tumour board in gastrointestinal cancers
Blog
Mar 26, 2025, 17:58
Enkeleda Duka shares her experience from ESO Clinical Training Centres Fellowship program